GILEAD SCIENCES WILL BE ABLE TO MEET THE GLOBAL REMDESIVIR DEMAND BY OCTOBER

Highlights

• By the year-end, it plans to produce more than 2 million treatment courses
• Since January, it has increased supply of the drug more than 50-fold

Gilead Sciences said on Thursday that it will be able to meet the global demand of remdesivir for the coronavirus pandemic by October. In addition, the biotech firm said that by the end of the year, it plans to produce more than....